“Clinicians must retain the latitude to prescribe medications based on individual patient factors and preferences.”
Pearl of the Month
Sarcoidosis should always be part of the differential when you see lymphopenia.
From the Journals
Acquired TTP often appears to arise in connection with either an immune trigger, such as a viral infection, or immune dysregulation associated...
A model that combines machine learning with clinical cues could help clinicians easily differentiate MIS-C from typhus, a new study found.
First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.
The ongoing prospective multicenter trial is the largest of its kind.
Dermatologists are using a variety of treatments for palmoplantar pustulosis, with no clear first-line choices.
“We now have the potential to change the way genetic epilepsies are treated by addressing the underlying genetic cause of the disease instead of...
“What’s really striking, and in my mind the most impressive, is that when you follow these patients out 3 or 4 years ... you see there is this...
"Now I hope you understand why we are so excited," said lead investigator Sonja Ständer, MD.
Despite being approved in Europe, Oleogel-S10 has not yet been approved to treat EB in the United States.